Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proxalutamide Treatment for Hospitalized COVID-19 Patients in Southern Brazil - The South Proxa-Rescue AndroCoV Trial

NCT05126628 is registered in ClinicalTrials.gov with Corpometria Institute as lead sponsor.

NCT NCT05126628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05126628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proxalutamide Treatment for Hospitalized COVID-19 Patients in Southern Brazil - The South Proxa-Rescue AndroCoV Trial
Lead sponsor
Corpometria Institute
Phase
Phase 3
Overall status
Completed
Start date
March 6, 2021
Completion date
April 15, 2021
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19